- Home
- ATHA vs AIRI Comparison
ATHA vs AIRI Comparison
Compare ATHA & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- AIRI
- Stock Information
- Founded
- ATHA 2011
- AIRI 1979
- Country
- ATHA United States
- AIRI United States
- Employees
- ATHA N/A
- AIRI N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- AIRI Military/Government/Technical
- Sector
- ATHA Health Care
- AIRI Industrials
- Exchange
- ATHA Nasdaq
- AIRI Nasdaq
- Market Cap
- ATHA 14.8M
- AIRI 15.2M
- IPO Year
- ATHA 2020
- AIRI N/A
- Fundamental
- Price
- ATHA $4.07
- AIRI $3.17
- Analyst Decision
- ATHA
- AIRI
- Analyst Count
- ATHA 0
- AIRI 0
- Target Price
- ATHA N/A
- AIRI N/A
- AVG Volume (30 Days)
- ATHA 47.2K
- AIRI 43.2K
- Earning Date
- ATHA 11-06-2025
- AIRI 11-13-2025
- Dividend Yield
- ATHA N/A
- AIRI N/A
- EPS Growth
- ATHA N/A
- AIRI N/A
- EPS
- ATHA N/A
- AIRI N/A
- Revenue
- ATHA N/A
- AIRI $52,277,000.00
- Revenue This Year
- ATHA N/A
- AIRI N/A
- Revenue Next Year
- ATHA N/A
- AIRI $3.53
- P/E Ratio
- ATHA N/A
- AIRI N/A
- Revenue Growth
- ATHA N/A
- AIRI N/A
- 52 Week Low
- ATHA $2.20
- AIRI $2.80
- 52 Week High
- ATHA $8.26
- AIRI $6.41
- Technical
- Relative Strength Index (RSI)
- ATHA 74.28
- AIRI 52.72
- Support Level
- ATHA $4.01
- AIRI $3.03
- Resistance Level
- ATHA $4.59
- AIRI $3.18
- Average True Range (ATR)
- ATHA 0.30
- AIRI 0.10
- MACD
- ATHA -0.05
- AIRI 0.01
- Stochastic Oscillator
- ATHA 47.32
- AIRI 72.92
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.